Lumos Pharma, Inc. Profile Avatar - Palmy Investing

Lumos Pharma, Inc.

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phas…

Biotechnology
US, Austin [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of LUMO's Analysis
CIK: 1126234 CUSIP: 55028X109 ISIN: US55028X1090 LEI: - UEI: -
Secondary Listings
LUMO has no secondary listings inside our databases.